These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 33567656)
1. Impact of Adjuvant Chemotherapy on Survival of Patients with Advanced Residual Disease at Radical Cystectomy following Neoadjuvant Chemotherapy: Systematic Review and Meta-Analysis. Krajewski W; Nowak Ł; Moschini M; Poletajew S; Chorbińska J; Necchi A; Montorsi F; Briganti A; Sanchez-Salas R; Shariat SF; Palou J; Babjuk M; Teoh JY; Soria F; Pradere B; Ornaghi PI; Pawlak A; Dembowski J; Zdrojowy R J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33567656 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis. Vetterlein MW; Seisen T; May M; Nuhn P; Gierth M; Mayr R; Fritsche HM; Burger M; Novotny V; Froehner M; Wirth MP; Protzel C; Hakenberg OW; Roghmann F; Palisaar RJ; Noldus J; Pycha A; Bastian PJ; Trinh QD; Xylinas E; Shariat SF; Rink M; Chun FK; Dahlem R; Fisch M; Aziz A; Eur Urol Focus; 2018 Mar; 4(2):252-259. PubMed ID: 28753775 [TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy in patients with locally advanced bladder cancer after neoadjuvant chemotherapy and radical cystectomy: a systematic review and pooled analysis. Cai Z; Jin H; Chen J; Hu J; Li H; Yi Z; Zu X Transl Androl Urol; 2021 Jan; 10(1):283-291. PubMed ID: 33532317 [TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant and adjuvant treatments in muscle-invasive bladder cancer: Where are we? Osanto S; Álvarez Gómez de Segura C Arch Esp Urol; 2020 Dec; 73(10):971-985. PubMed ID: 33269716 [TBL] [Abstract][Full Text] [Related]
5. Clinical role of additional adjuvant chemotherapy in patients with locally advanced urothelial carcinoma following neoadjuvant chemotherapy and cystectomy. Zargar-Shoshtari K; Kongnyuy M; Sharma P; Fishman MN; Gilbert SM; Poch MA; Pow-Sang JM; Spiess PE; Zhang J; Sexton WJ World J Urol; 2016 Nov; 34(11):1567-1573. PubMed ID: 27072536 [TBL] [Abstract][Full Text] [Related]
6. The role of adjuvant chemotherapy after radical surgery in patients with lymph node-positive bladder cancer or locally advanced (pT3, pT4a) bladder cancer: a meta-analysis and systematic review. Chen C; Wang C; Huang H; Li H; Wen Z; Liu Y; Yang XS Int J Surg; 2024 Nov; 110(11):7268-7280. PubMed ID: 39017737 [TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant and adjuvant chemotherapy share equivalent efficacy in improving overall survival and cancer-specific survival among muscle invasive bladder cancer patients who undergo radical cystectomy: a retrospective cohort study based on SEER database. Tan Z; Chen Z; Yao G; Mumin MA; Wang Y; Zhu J; Xu Q; Chen W; Liang H; Wang Z; Deng Q; Luo J; Wei J; Cao J Transl Androl Urol; 2023 Feb; 12(2):330-346. PubMed ID: 36915890 [TBL] [Abstract][Full Text] [Related]
8. Randomised phase III study of neoadjuvant chemotherapy with methotrexate, doxorubicin, vinblastine and cisplatin followed by radical cystectomy compared with radical cystectomy alone for muscle-invasive bladder cancer: Japan Clinical Oncology Group Study JCOG0209. Kitamura H; Tsukamoto T; Shibata T; Masumori N; Fujimoto H; Hirao Y; Fujimoto K; Kitamura Y; Tomita Y; Tobisu K; Niwakawa M; Naito S; Eto M; Kakehi Y; Ann Oncol; 2014 Jun; 25(6):1192-8. PubMed ID: 24669010 [TBL] [Abstract][Full Text] [Related]
9. Persistent muscle-invasive bladder cancer after neoadjuvant chemotherapy: an analysis of Surveillance, Epidemiology and End Results-Medicare data. Lane G; Risk M; Fan Y; Krishna S; Konety B BJU Int; 2019 May; 123(5):818-825. PubMed ID: 30126053 [TBL] [Abstract][Full Text] [Related]
10. A systematic review and meta-analysis on the oncological long-term outcomes after trimodality therapy and radical cystectomy with or without neoadjuvant chemotherapy for muscle-invasive bladder cancer. Fahmy O; Khairul-Asri MG; Schubert T; Renninger M; Malek R; Kübler H; Stenzl A; Gakis G Urol Oncol; 2018 Feb; 36(2):43-53. PubMed ID: 29102254 [TBL] [Abstract][Full Text] [Related]
11. Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2-4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 Trials. Bandini M; Briganti A; Plimack ER; Niegisch G; Yu EY; Bamias A; Agarwal N; Sridhar SS; Sternberg CN; Vaishampayan U; Théodore C; Rosenberg JE; Bellmunt J; Galsky MD; Montorsi F; Necchi A Eur Urol Oncol; 2019 May; 2(3):248-256. PubMed ID: 31200838 [TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant and Adjuvant Chemotherapy for Variant Histology Bladder Cancers: A Systematic Review and Meta-Analysis. Zhu Z; Xiao Y; Hu S; Wang Z; Zhu Z Front Oncol; 2022; 12():907454. PubMed ID: 35912201 [TBL] [Abstract][Full Text] [Related]
13. Role of adjuvant cisplatin-based chemotherapy following radical cystectomy in locally advanced muscle-invasive bladder cancer: Systematic review and meta-analysis of randomized trials. Kim DK; Lee JY; Jung JH; Hah YS; Cho KS Investig Clin Urol; 2019 Mar; 60(2):64-74. PubMed ID: 30838338 [TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer: The likelihood of initiation and completion. Eldefrawy A; Soloway MS; Katkoori D; Singal R; Pan D; Manoharan M Indian J Urol; 2012 Oct; 28(4):424-6. PubMed ID: 23449818 [TBL] [Abstract][Full Text] [Related]
15. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis. Bhindi B; Frank I; Mason RJ; Tarrell RF; Thapa P; Cheville JC; Costello BA; Pagliaro LC; Karnes RJ; Thompson RH; Tollefson MK; Boorjian SA Eur Urol; 2017 Nov; 72(5):660-664. PubMed ID: 28545841 [TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy is possibly beneficial for locally advanced or node-positive bladder cancer. Kanatani A; Nakagawa T; Kawai T; Naito A; Sato Y; Yoshida K; Nozaki K; Nagata M; Yamada Y; Azuma T; Suzuki M; Fujimura T; Fukuhara H; Nishimatsu H; Kume H; Igawa Y; Homma Y Clin Genitourin Cancer; 2015 Apr; 13(2):e107-12. PubMed ID: 25456839 [TBL] [Abstract][Full Text] [Related]
17. Effect of neoadjuvant chemotherapy on overall survival of patients with T2-4aN0M0 bladder cancer: A systematic review and meta-analysis according to EAU COVID-19 recommendation. Kang DH; Cho KS; Moon YJ; Chung DY; Jung HD; Lee JY PLoS One; 2022; 17(4):e0267410. PubMed ID: 35446917 [TBL] [Abstract][Full Text] [Related]
18. Superior efficacy of neoadjuvant chemotherapy and radical cystectomy in cT3-4aN0M0 compared to cT2N0M0 bladder cancer. Hermans TJN; Voskuilen CS; Deelen M; Mertens LS; Horenblas S; Meijer RP; Boormans JL; Aben KK; van der Heijden MS; Pos FJ; de Wit R; Beerepoot LV; Verhoeven RHA; van Rhijn BWG Int J Cancer; 2019 Mar; 144(6):1453-1459. PubMed ID: 30155893 [TBL] [Abstract][Full Text] [Related]
19. Survival Outcomes of Patients with Pathologically Proven Positive Lymph Nodes at Time of Radical Cystectomy with or without Neoadjuvant Chemotherapy. Ploussard G; Pradere B; Beauval JB; Chevreau C; Almeras C; Suc E; Gautier JR; Laurenty AP; Roumiguié M; Loison G; Tollon C; Mourey L; Salin A; Xylinas E; Pouessel D J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32585894 [TBL] [Abstract][Full Text] [Related]
20. [IMPACT OF ADJUVANT CHEMOTHERAPY AFTER RADICAL CYSTECTOMY FOR PATIENTS WITH LOCALLY ADVANCED BLADDER CANCER]. Minato A; Tomisaki I; Kimuro R; Higashijima K; Harada M; Jojima K; Sakamoto T; Takaba T; Ohno D; Kuretake K; Tanigawa K; Matsukawa T; Harada K; Fujimoto N Nihon Hinyokika Gakkai Zasshi; 2023; 114(4):99-107. PubMed ID: 39428549 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]